MT-2111

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-2111, covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL [Phase 1, Phase 2]